The Asia Pacific Tonometer Market would witness market growth of 6.3% CAGR during the forecast period (2023-2030).
Glaucoma is a public health concern and a top priority for policymakers and healthcare planners due to its high prevalence and high risk of blindness, with a focus on the requirement for glaucoma treatments for early detection as well as treatment to prevent blindness. Early detection is essential to stop glaucoma from progressing.
The market is expected to grow in the near future as more patients become aware of the importance of early diagnosis and consistent intraocular pressure (IOP) monitoring to avert preventable vision loss. The increasing number of glaucoma screening programs conducted by private, public, and semi-public healthcare sectors is likely to fuel market expansion throughout the forecast period, as is the availability of advantageous reimbursement policies for tonometers. The need for tonometers is driven by an increase in the number of eye checkup clinics, which raises awareness of glaucoma and its effects on vision. Additionally, market expansion is being promoted by the rising number of eye screening programs.
According to the National Library of Medicine, through many studies, it has been observed that the Asian populations, particularly those of East Asian ancestry, have frequently been reported to have the highest incidence of primary angle-closure glaucoma (PACG). NTG was discovered to be responsible for 92% of open-angle glaucoma instances in Japan, according to a Japanese study, the GRF reported. Thus, the predisposition of the region’s population to glaucoma has increased awareness of the disease among the masses. This has increased the number of visits to ophthalmic clinics for regular checkups, hence propelling the expansion of the market.
The China market dominated the Asia Pacific Tonometer Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $43.3 million by 2030. The Japan market is anticipated to grow at a CAGR of 5.6% during (2023 - 2030). Additionally, The India market would register a CAGR of 6.9% during (2023 - 2030).
Based on Type, the market is segmented into Applanation Tonometer, Rebound Tonometer, Indentation Tonometer, and Pascal Dynamic Contour Tonometer. Based on End-Use, the market is segmented into Ophthalmic Centers, Hospitals and Others. Based on Portability, the market is segmented into Desktop and Handheld. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Keeler Ltd. (Halma plc), Topcon Corporation, Revenio Group Oyj (Icare Finland Oy), Reichert, Inc. (Ametek, Inc.), OCULUS Optikgerate GmbH, Kowa American Corporation (Kowa Company, Ltd.), Nidek Co., Ltd., Ziemer Ophthalmic Systems AG, Canon, Inc. (Canon Medical Systems Corporation), and Tomey Corporation
Scope of the Study
Market Segments covered in the Report:
By Type

  • Applanation Tonometer
  • Rebound Tonometer
  • Indentation Tonometer
  • Pascal Dynamic Contour Tonometer


By End-Use

  • Ophthalmic Centers
  • Hospitals
  • Others


By Portability

  • Desktop
  • Handheld


By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific


Companies Profiled

  • Keeler Ltd. (Halma plc)
  • Topcon Corporation
  • Revenio Group Oyj (Icare Finland Oy)
  • Reichert, Inc. (Ametek, Inc.)
  • OCULUS Optikgerate GmbH
  • Kowa American Corporation (Kowa Company, Ltd.)
  • Nidek Co., Ltd.
  • Ziemer Ophthalmic Systems AG
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Tomey Corporation


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free